BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2020
View Archived Issues
New splicing factor implicated in muscular dystrophy
Read More
How cancer cells hibernate
Read More
Biallelic TKFC variants cause cataracts and human multisystem disease
Read More
CD206 activation by RP-182 improves adaptive and innate antitumor immunity by reprogramming TAMs
Read More
New CB1R agonist-positive allosteric modulators with improved drug-like physicochemical properties
Read More
New mouse model of gastric premalignancy integrating TP53 deletion with environmental exposures
Read More
FDA approves Pizensy for oral solution for chronic idiopathic constipation in adults
Read More
Givlaari receives European approval for Givlaari treatment of AHP in adults and adolescents
Read More
Phase II study of Diamyd in autoimmune diabetes opens for recruitment
Read More
uniQure and Gen-X collaborate to develop gene therapy synthetic promoters
Read More
Phase II data for nemolizumab in moderate-to-severe prurigo nodularis
Read More
PAR1 as a new therapeutic target for demyelinating disorders of the CNS
Read More
anti-SARS CoV antibody CR-3022 shows potent binding to 2019-nCoV spike protein
Read More
Bristol-Myers Squibb describes new protein-arginine deiminase type-4 inhibitors
Read More
New NLRP3 agonists discovered at Innate Tumor Immunity
Read More
Modern Biosciences patents anti-cancer compounds
Read More
First patient dosed in multiple ascending dose phase I study of LYT-100
Read More
Complement factor D inhibitors identified at Achillion
Read More
Medshine Discovery discloses new PI3K inhibitors
Read More
Nanoparticle vaccine elicits HBV therapeutic response
Read More
GBV-6249-192 demonstrates good preclinical results for treating primary open-angle glaucoma
Read More
Zydus receives approval to initiate phase I study of ZYBK-2 in India
Read More
Update for part A of ongoing phase I/IIa study of VBI-1901
Read More
NanoSurface announces NIH funding to support iPSC-based platform development
Read More
New phase II study investigates Telomelysin and radiotherapy for locally advanced esophageal cancer
Read More